Menezo J L, Marco M, Mascarell E V
J Fr Ophtalmol. 1978 Apr;1(4):289-94.
The authors have carried out a statistical study on two large groups of patients operated on for cataract and in whom the enzyme alph-chymotrypsin has been used, and the occurrence of ocular hypertension has been examined. One group, which contained 1,003 operations most of which were under the microscope using a firm closure technique, was compared with another group of 324 cases operated under the same conditions but without using the enzyme. In all cases the intraocular pressure was measured 24-48 hours after the operation. The rise in pressure, the rapidity of its development were studied together with its duration and the concentration of the enzyme. In addition these findings were compared with another group of 2,334 eyes operated on several years previously with standard techniques using a less hermetic wound suture, without a microscope, with alpha-chymotrypsin, but whose tensions were controlled from the third week. The results show conclusively that there is a greater frequency of the occurrence of raised intra-ocular pressure when the enzyme is used (40,3%) than when it is not used (25,3%). This ocular hypertension persists in all cases to the end of three weeks. The time of the appearance of the hypertension, the numbers affected and the duration of the intraocular pressure were not significantly meaningful in the statistical analysis.
作者对两组接受白内障手术且使用了α-糜蛋白酶的大量患者进行了统计研究,并检查了高眼压的发生情况。一组包含1003例手术,其中大部分是在显微镜下采用牢固闭合技术进行的,将其与另一组324例在相同条件下但未使用该酶的病例进行比较。在所有病例中,术后24至48小时测量眼压。研究了眼压升高情况、其发展速度、持续时间以及酶的浓度。此外,将这些结果与另一组2334只眼睛进行比较,这些眼睛是几年前采用标准技术、使用不太密闭的伤口缝合、不使用显微镜、使用α-糜蛋白酶进行手术的,但从第三周开始控制眼压。结果确凿地表明,使用该酶时高眼压的发生率(40.3%)高于未使用时(25.3%)。这种高眼压在所有病例中持续到三周结束。高血压出现的时间、受影响的数量以及眼压持续时间在统计分析中没有显著意义。